However, the invasion depth, AJCC stage, lymph node metastasis, and CRABP2 expression were not risk factors or protective factors for PFS of ESCC as shown in Table 7. This evidence concerns the gene CRABP2 and metastatic malignant neoplasm in the lymph nodes.